Gwo Xi Stem Cell Applied Technology (6704.TWO) Earnings Analysis
Gwo Xi Stem Cell Applied Technology (6704.TWO) next reports earnings on 2026-08-12. Trailing P/E -23.98.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 6704.TWO next report earnings?
| Next earnings date | 2026-08-12 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
6704.TWO earnings history — beats and misses
No reported earnings history is available for this symbol in our dataset.
6704.TWO valuation and analyst view
| Trailing P/E | -23.98 |
|---|---|
| Trailing EPS | -0.83917 TWD |
| Price / book | 3.29 |
| Dividend yield | 0.00% |
| Market cap | 1.95B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Gwo Xi Stem Cell Applied Technology (6704.TWO)'s next earnings date?
Gwo Xi Stem Cell Applied Technology is next scheduled to report on 2026-08-12.
What is 6704.TWO's current P/E ratio and EPS?
6704.TWO trades at a trailing P/E of -23.98 on trailing EPS of -0.8391749783739278 TWD.
What do analysts rate 6704.TWO?
6704.TWO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.